29 Aug 2019 | Medical Express
Three-quarters (75%) of Americans who expressed interest in using cannabis or cannabinoids to address pain are under the impression they are safer or have fewer side effects than opioids or other medications, according to a nationwide survey commissioned by the American Society of Anesthesiologists
29 Aug 2019 | The Scientist
After years of stalling, the agency says it plans to provide notice on pending applications from growers—but only after it establishes new regulations for suppliers.
29 Aug 2019 | Hanway
The National Institute for Health and Care Excellence (NICE) recently released its draft guidelines for prescribing cannabis-based medical products (CBMPs) in the UK.
28 Aug 2019 | Cleanroom Technology
The legalisation of cannabis for medicinal purposes pushes producers to supply chemists, physicians and patients with the newly approved drug in accordance with good manufacturing and distribution practices
21 Aug 2019 | Toronto Star
When Alexander Repetski’s daughter Gwen was born seven years ago, she was “extraordinarily healthy.” But by the time she was 18 months old, doctors were telling Alex and his wife to buy a wheelchair accessible van.
16 Aug 2019 | The New Zealand Medical Journal
With rapidly changing legislation designed to improve access to cannabis-based medicinal products, this paper assess the obligations of the law and professional bodies on the proposed prescribers of these products.
16 Aug 2019 | UK National Institute for Health and Care Excellence (NICE)
The National Institute for Health & Care Excellence (NICE), the body responsible for issuing guidance on whether certain medicines are recommended for use in healthcare, has recently published a draft of its official guidance on cannabis-based medicinal products.
9 Aug 2019 | JAMA Network
This article updates a review published in June 2015 by the Journal of the American Medical Association and describes newer evidence regarding what is known and not known about the efficacy of cannabis and cannabinoids for managing various conditions.
9 Aug 2019 | The Guardian
Medical cannabis cannot be approved for use in children with severe epilepsy on the National Health Service because there is not enough evidence to prove it helps, a watchdog has ruled.
8 Aug 2019 | Gallup
Galllup polling indicates fourteen percent of Americans say they use CBD-based products, and they are most likely to do so to relieve pain, anxiety and insomnia.